Trevena, Inc. (TRVN) Company Profile
Trevena Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops and intends to commercialize therapeutics that use an approach to target G protein coupled receptors (GPCRs). Using its product platform, the Company has identified and advanced three differentiated product candidates: Oliceridine (TRV130), TRV027 and TRV250. Its TRV130 is a Mu-receptor G protein Pathway Selective (Mu-GPS) modulator that activates G protein. Its TRV250 is a small molecule G protein biased ligand of the d-opioid receptor in preclinical development. Its TRV734 is a small molecule Mu-GPS that it has discovered and has developed through Phase I as a first-line, orally administered compound for the treatment of moderate to severe acute and chronic pain. Its TRV027 is a peptide b-arrestin biased ligand that targets the angiotensin II type 1 receptor (AT1R). In addition to these three product candidates, the Company has identified and has completed the Phase I program for TRV734.
News about TRVN
Somewhat Positive Press Coverage Somewhat Unlikely to Impact Trevena (TRVN) Share Price
Media stories about Trevena (NASDAQ:TRVN) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group rates the sentiment of media coverage by reviewing more than twenty million news and blog sources in r...Read More>>>
What I Learned About Bitcoin Could Make You A Fortune...
When I was first asked to write a book about bitcoin, the price was hovering at about $3,000. As part of my research, I bought a little. By the time the book was finished, which was really only a matter of weeks, the price had risen to just a tad ove...Read More>>>
Market Cycles Point Towards A Down Week For Stocks
Summary: · The S&P 500 moved higher last week, rising by 0.9%. · Uncertainty in Europe ticked up, as Angela Merkel’s attempt to form a coalition governmen...Read More>>>
Biotech Forum Daily Digest: ASCO Boosts Oncology Concerns. Spotlight On Trevena
"In the land of the blind, the one-eyed man is king." ― Erasmus ...Read More>>>
22 Stocks Moving In Thursday's Pre-Market Session
Gainers Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday. Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbe...Read More>>>